Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07335445 · ClinicalTrials.gov registry record · NA
Enhancing Screening Practices for BE
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Not yet
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
NCT07335445 is a NA study that has not yet begun recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 3,000 participants.
The verdict
NCT07335445, a NA study, has not yet begun recruiting, sponsored by Rutgers, The State University of New Jersey.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
Study Summary
Previous studies have shown that screening for Barrett's esophagus (BE), the main risk factor for esophageal adenocarcinoma, is under-utilized in the primary care setting. In fact less than 35% of eligible patients are screened despite endorsement for screening by the major GI societies in patients with risk factors. The purpose of this study is to examine current screening practices and determine if implementation of screening reminders can optimize screening practices for Barrett's Esophagus within a large, academic based healthcare system in NJ.
Interventions
- OTHER Screening Reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2026-05 |
| Est. Completion | 2029-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07335445
The ClinicalTrials.gov registry entry for NCT07335445 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Screening Reminder is the first listed.
NCT07335445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07335445 about?
NCT07335445 is a clinical study titled "Enhancing Screening Practices for BE". Previous studies have shown that screening for Barrett's esophagus (BE), the main risk factor for esophageal adenocarcinoma, is under-utilized in the primary care setting. In fact less than 35% of eligible patients are screened despite endorsement for screening by the major GI societies in patients ...
What is the current status of trial NCT07335445?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2026-05. Estimated completion is 2029-06.
What interventions are being tested in trial NCT07335445?
The interventions under investigation include: Screening Reminder (OTHER).
Who is sponsoring clinical trial NCT07335445?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.